- Home
- LVO vs TLSA Comparison
LVO vs TLSA Comparison
Compare LVO & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- TLSA
- Stock Information
- Founded
- LVO 2009
- TLSA 2013
- Country
- LVO United States
- TLSA United Kingdom
- Employees
- LVO N/A
- TLSA N/A
- Industry
- LVO Restaurants
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- TLSA Health Care
- Exchange
- LVO Nasdaq
- TLSA Nasdaq
- Market Cap
- LVO 89.7M
- TLSA 87.8M
- IPO Year
- LVO N/A
- TLSA 2000
- Fundamental
- Price
- LVO $0.83
- TLSA $0.90
- Analyst Decision
- LVO Strong Buy
- TLSA
- Analyst Count
- LVO 2
- TLSA 0
- Target Price
- LVO $2.75
- TLSA N/A
- AVG Volume (30 Days)
- LVO 614.2K
- TLSA 384.7K
- Earning Date
- LVO 11-07-2024
- TLSA 12-27-2024
- Dividend Yield
- LVO N/A
- TLSA N/A
- EPS Growth
- LVO N/A
- TLSA N/A
- EPS
- LVO N/A
- TLSA N/A
- Revenue
- LVO $127,817,000.00
- TLSA N/A
- Revenue This Year
- LVO $12.29
- TLSA N/A
- Revenue Next Year
- LVO $13.19
- TLSA N/A
- P/E Ratio
- LVO N/A
- TLSA N/A
- Revenue Growth
- LVO 17.10
- TLSA N/A
- 52 Week Low
- LVO $0.56
- TLSA $0.41
- 52 Week High
- LVO $2.15
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- LVO 50.81
- TLSA 46.21
- Support Level
- LVO $0.69
- TLSA $0.88
- Resistance Level
- LVO $0.95
- TLSA $1.27
- Average True Range (ATR)
- LVO 0.09
- TLSA 0.10
- MACD
- LVO 0.04
- TLSA -0.00
- Stochastic Oscillator
- LVO 65.32
- TLSA 10.00
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.